1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Harris, R.
Hillerich, B.
Ahmed, M.
Bonanno, J.B.
Chamala, S.
Evans, B.
Lafleur, J.
Hammonds, J.
Washington, E.
Stead, M.
Love, J.
Attonito, J.
Patel, H.
Seidel, R.D.
Chook, Y.M.
Rout, M.P.
Girvin, M.E.
Almo, S.C.
New York Structural Genomics Research Consortium (NYSGRC)
Nucleocytoplasmic Transport: a Target for Cellular Control (NPCXstals)
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
To be Published
0353
Solution structure of the RRM domain of the hypothetical protein CAGL0M09691g from Candida glabrata
10.2210/pdb2m4m/pdb
pdb_00002m4m
14227.867
hypothetical protein
UNP residues 171-283
1
man
polymer
no
no
MSLGSESETGNAVVVFGYREAITKQILAYFAQFGEILEDLESELGDTETMRTPGYFFQQAPNRRRISREHGRTWTKLTYA
NHSSYLRALREHGTIYCGAAIGCVPYKHELISELSREGHHHHHH
MSLGSESETGNAVVVFGYREAITKQILAYFAQFGEILEDLESELGDTETMRTPGYFFQQAPNRRRISREHGRTWTKLTYA
NHSSYLRALREHGTIYCGAAIGCVPYKHELISELSREGHHHHHH
A
NYSGRC-019428
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Yeast
CBS 138
sample
CAGL0M09691g
284593
Candida glabrata
469008
Escherichia coli
BL21(DE3)
modified pET26
pET
New York Structural Genomics Research Consortium
NYSGRC
PSI:Biology
Nucleocytoplasmic Transport: a Target for Cellular Control
NPCXstals
PSI:Biology
database_2
pdbx_database_status
pdbx_nmr_software
pdbx_nmr_spectrometer
struct_ref_seq_dif
repository
Initial release
Data collection
Database references
Other
1
0
2013-02-27
1
1
2023-06-14
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_nmr_data
_pdbx_nmr_software.name
_pdbx_nmr_spectrometer.model
_struct_ref_seq_dif.details
Y
BMRB
Y
RCSB
2013-02-07
REL
REL
REL
REL
1564
542
308
261
424
12
48
48
All 3D experiments were acquired with 30% non-uniform sampling using the MDDNMR approach
20 structures for lowest energy
100
20
15N HSQC
15N NOESY-HSQC
13C HSQC
aromatic 13C HSQC
13C NOESY-HSQC
13C aromatic NOESY-HSQC
HNCO
HNCACO
HNCA
HNCOCA
HNCACB
CBCACONH
1.0
mM
[U-100% 13C; U-100% 15N]
10
mM
100
mM
0.5
mM
0.5
mM
1.0
mM
[U-100% 13C; U-100% 15N]
10
mM
100
mM
0.5
mM
0.5
mM
110
4.5
1
atm
298
K
Refinement in a box of water
simulating annealing
1
lowest energy
1.0 mM [U-100% 13C; U-100% 15N] RRM domain of the hypothetical protein, 10 mM sodium acetate, 100 mM sodium chloride, 0.5 mM DTT, 0.5 mM EDTA, 90% H2O, 10% D2O
90% H2O/10% D2O
1.0 mM [U-100% 13C; U-100% 15N] RRM domain of the hypothetical protein, 10 mM sodium acetate, 100 mM sodium chloride, 0.5 mM DTT, 0.5 mM EDTA, 100% D2O
100% D2O
Brunger A. T. et.al.
refinement
CNS
1.21
Varian
collection
VnmrJ
2.2D
Bruker Biospin
collection
TopSpin
2.1
(MDDNMR) Orekhov, Jaravine, Kazimierczuk
collection
MddNMR
2.2
(MDDNMR) Orekhov, Jaravine, Kazimierczuk
processing
MddNMR
2.2
CCPN
data analysis
CCPN_Analysis
2.2
Linge, O'Donoghue and Nilges
data analysis
ARIA
2.3
Schwieters, Kuszewski, Tjandra and Clore
structure solution
X-PLOR NIH
2.32
refinement
X-PLOR NIH
600
Varian
INOVA
Varian Inova
800
Bruker
AVANCE
Bruker Avance
MET
1
n
1
MET
1
A
SER
2
n
2
SER
2
A
LEU
3
n
3
LEU
3
A
GLY
4
n
4
GLY
4
A
SER
5
n
5
SER
5
A
GLU
6
n
6
GLU
6
A
SER
7
n
7
SER
7
A
GLU
8
n
8
GLU
8
A
THR
9
n
9
THR
9
A
GLY
10
n
10
GLY
10
A
ASN
11
n
11
ASN
11
A
ALA
12
n
12
ALA
12
A
VAL
13
n
13
VAL
13
A
VAL
14
n
14
VAL
14
A
VAL
15
n
15
VAL
15
A
PHE
16
n
16
PHE
16
A
GLY
17
n
17
GLY
17
A
TYR
18
n
18
TYR
18
A
ARG
19
n
19
ARG
19
A
GLU
20
n
20
GLU
20
A
ALA
21
n
21
ALA
21
A
ILE
22
n
22
ILE
22
A
THR
23
n
23
THR
23
A
LYS
24
n
24
LYS
24
A
GLN
25
n
25
GLN
25
A
ILE
26
n
26
ILE
26
A
LEU
27
n
27
LEU
27
A
ALA
28
n
28
ALA
28
A
TYR
29
n
29
TYR
29
A
PHE
30
n
30
PHE
30
A
ALA
31
n
31
ALA
31
A
GLN
32
n
32
GLN
32
A
PHE
33
n
33
PHE
33
A
GLY
34
n
34
GLY
34
A
GLU
35
n
35
GLU
35
A
ILE
36
n
36
ILE
36
A
LEU
37
n
37
LEU
37
A
GLU
38
n
38
GLU
38
A
ASP
39
n
39
ASP
39
A
LEU
40
n
40
LEU
40
A
GLU
41
n
41
GLU
41
A
SER
42
n
42
SER
42
A
GLU
43
n
43
GLU
43
A
LEU
44
n
44
LEU
44
A
GLY
45
n
45
GLY
45
A
ASP
46
n
46
ASP
46
A
THR
47
n
47
THR
47
A
GLU
48
n
48
GLU
48
A
THR
49
n
49
THR
49
A
MET
50
n
50
MET
50
A
ARG
51
n
51
ARG
51
A
THR
52
n
52
THR
52
A
PRO
53
n
53
PRO
53
A
GLY
54
n
54
GLY
54
A
TYR
55
n
55
TYR
55
A
PHE
56
n
56
PHE
56
A
PHE
57
n
57
PHE
57
A
GLN
58
n
58
GLN
58
A
GLN
59
n
59
GLN
59
A
ALA
60
n
60
ALA
60
A
PRO
61
n
61
PRO
61
A
ASN
62
n
62
ASN
62
A
ARG
63
n
63
ARG
63
A
ARG
64
n
64
ARG
64
A
ARG
65
n
65
ARG
65
A
ILE
66
n
66
ILE
66
A
SER
67
n
67
SER
67
A
ARG
68
n
68
ARG
68
A
GLU
69
n
69
GLU
69
A
HIS
70
n
70
HIS
70
A
GLY
71
n
71
GLY
71
A
ARG
72
n
72
ARG
72
A
THR
73
n
73
THR
73
A
TRP
74
n
74
TRP
74
A
THR
75
n
75
THR
75
A
LYS
76
n
76
LYS
76
A
LEU
77
n
77
LEU
77
A
THR
78
n
78
THR
78
A
TYR
79
n
79
TYR
79
A
ALA
80
n
80
ALA
80
A
ASN
81
n
81
ASN
81
A
HIS
82
n
82
HIS
82
A
SER
83
n
83
SER
83
A
SER
84
n
84
SER
84
A
TYR
85
n
85
TYR
85
A
LEU
86
n
86
LEU
86
A
ARG
87
n
87
ARG
87
A
ALA
88
n
88
ALA
88
A
LEU
89
n
89
LEU
89
A
ARG
90
n
90
ARG
90
A
GLU
91
n
91
GLU
91
A
HIS
92
n
92
HIS
92
A
GLY
93
n
93
GLY
93
A
THR
94
n
94
THR
94
A
ILE
95
n
95
ILE
95
A
TYR
96
n
96
TYR
96
A
CYS
97
n
97
CYS
97
A
GLY
98
n
98
GLY
98
A
ALA
99
n
99
ALA
99
A
ALA
100
n
100
ALA
100
A
ILE
101
n
101
ILE
101
A
GLY
102
n
102
GLY
102
A
CYS
103
n
103
CYS
103
A
VAL
104
n
104
VAL
104
A
PRO
105
n
105
PRO
105
A
TYR
106
n
106
TYR
106
A
LYS
107
n
107
LYS
107
A
HIS
108
n
108
HIS
108
A
GLU
109
n
109
GLU
109
A
LEU
110
n
110
LEU
110
A
ILE
111
n
111
ILE
111
A
SER
112
n
112
SER
112
A
GLU
113
n
113
GLU
113
A
LEU
114
n
114
LEU
114
A
SER
115
n
115
SER
115
A
ARG
116
n
116
ARG
116
A
GLU
117
n
117
GLU
117
A
GLY
118
n
118
GLY
118
A
HIS
119
n
119
HIS
119
A
HIS
120
n
120
HIS
120
A
HIS
121
n
121
HIS
121
A
HIS
122
n
122
HIS
122
A
HIS
123
n
123
HIS
123
A
HIS
124
n
124
HIS
124
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
THR
75
A
O
THR
75
A
N
VAL
15
A
N
VAL
15
A
N
VAL
14
A
N
VAL
14
A
O
VAL
104
A
O
VAL
104
A
N
TYR
96
A
N
TYR
96
A
O
ALA
99
A
O
ALA
99
1
A
A
OE2
HH12
GLU
ARG
35
51
1.59
2
A
A
HZ2
OE1
LYS
GLU
24
41
1.60
3
A
A
HZ3
OE2
LYS
GLU
24
43
1.55
4
A
A
OE2
HH12
GLU
ARG
43
51
1.58
7
A
A
HZ1
OE2
LYS
GLU
24
41
1.60
8
A
A
O
HG1
ASP
THR
46
47
1.59
9
A
A
HZ1
OE1
LYS
GLU
24
41
1.59
9
A
A
O
HG
ALA
CYS
88
103
1.60
11
A
A
HZ3
OD2
LYS
ASP
24
39
1.57
12
A
A
HZ2
OD2
LYS
ASP
24
39
1.57
18
A
A
HZ1
OD1
LYS
ASP
24
39
1.58
19
A
A
O
HG1
ARG
THR
72
73
1.56
1
A
SER
5
61.43
-161.51
1
A
GLU
8
-121.01
-168.19
1
A
GLU
20
-68.77
4.73
1
A
SER
42
49.59
94.37
1
A
LEU
44
58.94
85.25
1
A
THR
47
75.20
-48.25
1
A
GLU
48
59.27
11.14
1
A
THR
49
49.16
24.43
1
A
THR
52
71.98
136.29
1
A
TYR
55
72.78
-40.95
1
A
ALA
80
69.67
-23.78
1
A
ARG
90
49.35
-113.08
1
A
HIS
120
-133.06
-37.76
1
A
HIS
123
74.54
-37.35
2
A
GLU
8
-102.18
59.83
2
A
THR
9
48.39
76.20
2
A
ARG
19
-74.21
-83.30
2
A
GLU
20
179.85
-52.56
2
A
ALA
21
-68.17
0.37
2
A
THR
23
-45.11
-71.59
2
A
GLU
38
-90.06
-138.85
2
A
ASP
39
71.19
-75.26
2
A
LEU
40
38.34
88.63
2
A
GLU
41
-114.22
-74.73
2
A
GLU
43
42.31
82.47
2
A
LEU
44
56.71
-172.80
2
A
ASP
46
70.99
-31.80
2
A
MET
50
64.39
74.70
2
A
GLN
58
69.56
122.40
2
A
ASN
62
54.24
84.82
2
A
ARG
65
-178.63
-173.44
2
A
SER
67
-77.08
20.51
2
A
ARG
72
-91.48
-76.35
2
A
ALA
80
69.71
-41.37
2
A
TYR
106
-59.26
106.82
2
A
HIS
121
71.73
-46.80
2
A
HIS
123
-124.85
-167.02
3
A
LEU
3
62.91
-176.10
3
A
GLU
8
51.74
86.05
3
A
GLU
20
-69.32
85.46
3
A
ALA
21
-171.47
-37.18
3
A
THR
23
-45.04
-72.88
3
A
GLU
35
66.45
112.66
3
A
ILE
36
-145.65
-47.86
3
A
GLU
41
-176.54
123.14
3
A
SER
42
57.73
83.80
3
A
GLU
43
-135.37
-66.28
3
A
THR
47
59.69
15.81
3
A
THR
52
59.85
81.25
3
A
ARG
72
-111.64
-73.17
3
A
ALA
80
71.80
-34.51
3
A
ARG
90
-47.65
89.66
3
A
GLU
91
-158.84
88.72
3
A
HIS
121
72.61
137.41
3
A
HIS
123
63.68
-82.30
4
A
ARG
19
-90.00
-83.14
4
A
GLU
20
-178.32
-42.25
4
A
LEU
37
69.14
-178.93
4
A
LEU
40
-100.88
-104.50
4
A
GLU
41
66.26
147.56
4
A
GLU
43
-77.76
-82.64
4
A
THR
52
57.35
125.18
4
A
GLN
58
54.34
79.34
4
A
GLN
59
40.57
79.69
4
A
ARG
63
-132.91
-157.08
4
A
ARG
72
-174.57
-43.32
4
A
ALA
80
71.28
-45.71
4
A
HIS
92
-168.08
91.60
4
A
CYS
97
70.37
-52.79
4
A
HIS
120
-85.48
45.32
5
A
ALA
21
178.79
-33.38
5
A
ALA
31
-59.99
-6.79
5
A
PHE
33
-138.24
-69.37
5
A
LEU
37
64.59
-167.48
5
A
GLU
41
62.22
-81.54
5
A
LEU
44
45.97
73.51
5
A
GLN
59
-169.89
99.11
5
A
ARG
72
-161.62
-54.40
5
A
GLU
91
-162.06
85.01
5
A
HIS
92
-150.25
24.31
5
A
GLU
117
-162.93
-68.95
5
A
HIS
122
65.39
-62.42
5
A
HIS
123
-147.67
-34.49
6
A
SER
7
57.13
18.29
6
A
GLU
8
58.31
19.13
6
A
GLN
25
-93.02
-67.44
6
A
ALA
31
-42.11
-13.01
6
A
LEU
40
-129.81
-81.18
6
A
GLU
41
64.88
-63.63
6
A
GLU
43
-124.20
-144.47
6
A
PHE
57
44.50
-178.26
6
A
ALA
80
80.90
-1.31
6
A
ARG
90
47.44
-137.45
6
A
HIS
120
-82.40
32.56
6
A
HIS
121
62.31
-101.54
7
A
SER
2
-157.58
-21.01
7
A
SER
7
-106.60
69.80
7
A
THR
9
-92.56
-69.21
7
A
ALA
21
-171.05
-30.74
7
A
ILE
36
-120.67
-83.51
7
A
LEU
37
-67.17
-75.21
7
A
GLU
38
-175.89
39.83
7
A
THR
52
53.51
176.43
7
A
PRO
53
-69.74
20.18
7
A
GLN
58
-46.66
103.50
7
A
ALA
60
65.01
159.18
7
A
SER
67
174.63
-42.66
7
A
ARG
72
-122.65
-143.10
7
A
THR
73
-77.79
36.02
7
A
ALA
80
70.67
-44.72
7
A
ARG
90
-62.27
36.17
7
A
HIS
92
-137.07
-70.51
7
A
PRO
105
-75.30
45.92
7
A
TYR
106
58.70
111.72
7
A
GLU
117
46.82
25.13
8
A
THR
9
71.74
-58.99
8
A
ALA
21
-177.07
-32.73
8
A
LEU
37
68.76
-176.10
8
A
LEU
40
-133.10
-77.73
8
A
GLU
41
68.72
-66.34
8
A
SER
42
-154.16
89.51
8
A
GLU
43
-79.37
-73.88
8
A
THR
47
57.81
18.60
8
A
THR
52
57.16
175.63
8
A
PRO
53
-76.35
26.07
8
A
PHE
56
-65.10
-72.28
8
A
PHE
57
-170.91
129.89
8
A
ARG
65
51.74
-94.57
8
A
GLU
91
-126.23
-119.97
8
A
HIS
92
54.66
-96.47
8
A
HIS
120
49.84
-131.58
9
A
THR
9
72.78
-39.10
9
A
TYR
29
-92.41
-72.36
9
A
ILE
36
-123.44
-80.37
9
A
ASP
39
70.38
83.36
9
A
LEU
40
-104.91
-60.15
9
A
GLU
41
54.62
-128.38
9
A
LEU
44
-131.28
-51.19
9
A
ASP
46
76.54
-41.05
9
A
THR
52
46.32
88.73
9
A
GLN
59
-88.25
-138.41
9
A
ALA
60
71.36
164.35
9
A
ARG
64
59.00
176.70
9
A
ILE
66
53.53
122.58
9
A
ALA
80
67.44
-55.47
9
A
ARG
90
-31.37
100.03
9
A
GLU
91
-165.24
78.30
9
A
GLU
117
62.76
69.05
9
A
HIS
122
177.24
110.83
10
A
SER
7
71.71
85.93
10
A
THR
9
60.26
84.60
10
A
THR
23
-44.26
-71.45
10
A
GLN
25
-60.77
-71.36
10
A
ALA
31
-38.19
-29.32
10
A
ILE
36
-134.40
-63.47
10
A
ASP
39
71.78
171.79
10
A
LEU
40
-115.33
-79.52
10
A
GLU
41
-150.64
-40.42
10
A
GLU
43
-132.35
-57.92
10
A
TYR
55
77.09
167.89
10
A
ALA
60
65.57
161.18
10
A
SER
67
155.96
-35.47
10
A
ARG
72
-169.80
-56.18
10
A
TYR
106
-61.78
98.70
11
A
ALA
21
-151.50
-36.09
11
A
ILE
22
-82.86
30.20
11
A
THR
23
-46.71
-76.68
11
A
TYR
29
-94.78
-63.35
11
A
LEU
40
-172.07
109.75
11
A
GLU
41
-128.77
-73.40
11
A
GLU
43
-126.93
-66.58
11
A
ARG
51
-142.14
-83.91
11
A
PHE
56
-167.89
-70.56
11
A
PHE
57
42.56
27.71
11
A
GLN
58
70.39
-44.76
11
A
ILE
66
-100.08
-157.93
11
A
THR
73
57.90
10.03
11
A
ALA
80
71.44
-63.82
11
A
HIS
123
-171.14
119.64
12
A
GLU
6
-102.60
72.02
12
A
THR
9
71.85
-58.51
12
A
ARG
19
-85.07
-86.59
12
A
GLU
20
-165.16
-65.91
12
A
ILE
36
-137.35
-76.09
12
A
LEU
40
-126.58
-71.24
12
A
GLU
41
65.01
-70.39
12
A
GLU
43
-91.07
-74.07
12
A
LEU
44
-126.93
-51.88
12
A
THR
47
-79.59
-91.31
12
A
GLU
48
65.48
-37.08
12
A
THR
52
58.94
159.93
12
A
ALA
60
72.64
142.90
12
A
ASN
62
-107.63
-80.59
12
A
ALA
80
69.88
-61.72
12
A
CYS
97
70.42
-15.39
12
A
LYS
107
63.24
124.56
13
A
SER
2
66.45
93.25
13
A
SER
5
70.51
162.67
13
A
SER
7
-167.72
100.29
13
A
GLU
20
-67.41
77.39
13
A
ALA
21
-175.07
-30.39
13
A
ILE
22
-87.12
34.64
13
A
LEU
37
75.53
167.46
13
A
ASP
39
-65.09
-79.90
13
A
LEU
40
42.62
87.99
13
A
SER
42
-158.06
83.61
13
A
GLU
43
-90.45
-80.11
13
A
GLU
48
-80.38
37.39
13
A
MET
50
-78.55
37.89
13
A
GLN
58
72.15
116.46
13
A
ARG
64
-69.25
87.07
13
A
GLU
91
-146.21
13.01
13
A
HIS
92
-110.97
-70.35
13
A
TYR
106
-63.72
95.83
13
A
GLU
117
70.05
96.53
13
A
HIS
123
65.38
-81.00
14
A
SER
7
-90.00
-136.05
14
A
ALA
21
-176.62
-29.88
14
A
ILE
22
-97.53
31.24
14
A
ILE
36
-107.09
-77.55
14
A
ASP
39
52.36
76.69
14
A
GLU
41
43.63
-94.27
14
A
GLU
43
-63.81
-78.43
14
A
LEU
44
-160.87
-54.58
14
A
ASP
46
-91.37
-85.04
14
A
THR
47
-90.38
37.70
14
A
THR
52
65.51
122.95
14
A
PRO
53
-76.99
47.23
14
A
GLN
58
-56.44
98.98
14
A
ARG
72
-128.09
-85.57
14
A
ALA
80
70.36
-53.61
14
A
ARG
90
-58.10
86.60
14
A
HIS
92
-59.79
91.78
14
A
CYS
97
73.62
-37.01
14
A
TYR
106
-56.89
102.29
14
A
GLU
117
51.28
81.35
14
A
HIS
119
55.05
-64.22
14
A
HIS
121
-93.86
-81.14
14
A
HIS
123
70.95
-46.12
15
A
THR
9
-94.17
30.77
15
A
ALA
21
-168.23
-39.66
15
A
PHE
33
-95.75
-67.65
15
A
LEU
40
-173.14
101.86
15
A
GLU
43
-90.99
-78.85
15
A
THR
47
-164.32
33.20
15
A
THR
52
57.97
158.77
15
A
PRO
53
-69.91
-156.25
15
A
GLN
58
66.91
120.78
15
A
GLN
59
-69.60
88.75
15
A
ALA
80
69.95
-36.23
15
A
ARG
90
-49.04
108.94
15
A
TYR
106
-60.03
97.86
16
A
SER
5
69.59
163.14
16
A
SER
7
-115.78
-113.35
16
A
ALA
21
-158.49
9.19
16
A
GLU
41
-97.50
-81.05
16
A
SER
42
-103.88
-61.90
16
A
GLU
43
65.43
100.29
16
A
LEU
44
51.22
-137.63
16
A
THR
52
56.60
174.28
16
A
GLN
58
59.75
172.97
16
A
GLN
59
-132.24
-75.09
16
A
ALA
60
43.70
84.27
16
A
ALA
80
68.31
-59.37
16
A
ARG
90
-53.43
102.08
16
A
GLU
117
64.83
80.07
16
A
HIS
122
-153.01
-58.61
17
A
LEU
37
50.77
-107.57
17
A
GLU
38
-169.31
-54.16
17
A
LEU
40
-70.76
-74.99
17
A
GLU
41
65.05
-74.78
17
A
GLU
43
-105.55
-93.61
17
A
ASP
46
75.46
169.12
17
A
GLN
58
74.96
97.89
17
A
ARG
72
-86.94
-82.98
17
A
ALA
80
66.53
-1.19
17
A
THR
94
54.65
-165.04
17
A
CYS
97
71.46
-36.40
18
A
LEU
3
55.18
-89.11
18
A
SER
5
64.64
-50.56
18
A
SER
7
-114.95
-149.26
18
A
THR
9
71.66
-68.73
18
A
ILE
22
-88.35
30.78
18
A
THR
23
-43.90
-73.50
18
A
LEU
37
71.82
-107.35
18
A
GLU
38
-164.13
-67.77
18
A
ASP
39
62.74
-169.82
18
A
LEU
40
-160.80
3.77
18
A
THR
47
-83.07
-84.28
18
A
GLU
48
66.39
-38.31
18
A
ARG
51
-129.40
-140.75
18
A
PRO
53
-74.92
38.33
18
A
ALA
60
63.76
149.86
18
A
ARG
63
-119.77
-153.31
18
A
ARG
64
-55.88
101.02
18
A
SER
67
170.94
-42.57
18
A
ARG
72
51.32
-90.20
18
A
ALA
80
68.12
-48.81
18
A
ARG
90
-37.88
130.78
18
A
GLU
91
-136.40
-153.88
18
A
GLU
117
61.77
64.60
19
A
LEU
3
50.20
76.54
19
A
ILE
22
-99.42
30.98
19
A
PHE
33
-158.89
53.32
19
A
LEU
37
64.67
-169.27
19
A
GLU
41
54.97
-92.48
19
A
GLU
43
-100.20
-105.81
19
A
LEU
44
-118.66
-74.13
19
A
THR
52
168.94
158.62
19
A
GLN
58
-63.68
15.05
19
A
ILE
66
-50.64
-72.58
19
A
SER
67
46.01
21.78
19
A
THR
73
72.19
-11.20
19
A
ALA
80
70.22
-5.28
19
A
ARG
90
56.75
-120.65
19
A
HIS
119
70.49
143.20
20
A
GLU
20
-78.08
46.35
20
A
THR
23
-50.94
-73.67
20
A
GLN
25
-66.61
-71.59
20
A
LEU
37
72.98
-177.71
20
A
GLU
41
85.24
-53.00
20
A
LEU
44
-115.06
-165.98
20
A
THR
52
61.69
120.21
20
A
TYR
55
73.38
87.29
20
A
PHE
56
61.73
119.59
20
A
GLN
58
62.66
99.00
20
A
ALA
60
58.08
104.34
20
A
ASN
62
80.64
-15.49
20
A
ARG
63
-104.54
-158.74
20
A
ARG
72
-105.57
-72.25
20
A
ALA
80
73.18
-53.51
lowest energy, model1
Solution structure of the RRM domain of the hypothetical protein CAGL0M09691g from Candida glabrata
1
N
N
A
ILE
22
A
ILE
22
HELX_P
A
ALA
31
A
ALA
31
1
1
10
A
THR
47
A
THR
47
HELX_P
A
ARG
51
A
ARG
51
5
2
5
A
ASN
81
A
ASN
81
HELX_P
A
ARG
90
A
ARG
90
1
3
10
A
LYS
107
A
LYS
107
HELX_P
A
GLY
118
A
GLY
118
1
4
12
UNKNOWN FUNCTION
STRUCTURAL GENOMICS, UNKNOWN FUNCTION, THIOREDOXIN-LIKE, New York Structural Genomics Research Consortium, NYSGRC, Nucleocytoplasmic Transport: a Target for Cellular Control, PSI-Biology, NPCXstals
Q6FJ27_CANGA
UNP
1
171
Q6FJ27
GSESETGNAVVVFGYREAITKQILAYFAQFGEILEDLESELGDTETMRTPGYFFQQAPNRRRISREHGRTWTKLTYANHS
SYLRALREHGTIYCGAAIGCVPYKHELISELSR
171
283
2M4M
4
116
Q6FJ27
A
1
4
116
1
expression tag
MET
1
2M4M
A
Q6FJ27
UNP
1
1
expression tag
SER
2
2M4M
A
Q6FJ27
UNP
2
1
expression tag
LEU
3
2M4M
A
Q6FJ27
UNP
3
1
expression tag
GLU
117
2M4M
A
Q6FJ27
UNP
117
1
expression tag
GLY
118
2M4M
A
Q6FJ27
UNP
118
1
expression tag
HIS
119
2M4M
A
Q6FJ27
UNP
119
1
expression tag
HIS
120
2M4M
A
Q6FJ27
UNP
120
1
expression tag
HIS
121
2M4M
A
Q6FJ27
UNP
121
1
expression tag
HIS
122
2M4M
A
Q6FJ27
UNP
122
1
expression tag
HIS
123
2M4M
A
Q6FJ27
UNP
123
1
expression tag
HIS
124
2M4M
A
Q6FJ27
UNP
124
3
2
anti-parallel
anti-parallel
anti-parallel
A
TRP
74
A
TRP
74
A
THR
78
A
THR
78
A
ALA
12
A
ALA
12
A
PHE
16
A
PHE
16
A
GLY
102
A
GLY
102
A
PRO
105
A
PRO
105
A
ILE
95
A
ILE
95
A
TYR
96
A
TYR
96
A
ALA
99
A
ALA
99
A
ALA
100
A
ALA
100